Position
Fidelity in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $82.2K$2.47 → $3.24
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 141.7K | $290.4K | — | — | — | 0.0% |
| Q1 2026 | 106.8K | $263.7K | $2.47 | $44.8K | −$71.5K | 0.0% |
| Q2 2026 | 111.2K | $360.3K | $3.24 | $82.2K | $14.3K | 0.0% |